22:36 , Apr 4, 2018 |  BC Innovations  |  Translation in Brief

New Therapeutic Targets and Biomarkers: March 2018

New Therapeutic Targets and Biomarkers: March 2018 Select top therapeutic targets and biomarkers covered by BioCentury or added to the BCIQ database during March 2018. Therapeutic targets are defined as any protein, gene or other molecule...
23:20 , Mar 27, 2018 |  BC Innovations  |  Distillery Therapeutics

Infectious disease

INDICATION: Bacterial infection Chimeric antigens against N. meningitidis fHbp and N. meningitidis porA could be used to develop vaccines against serogroup B N. meningitidis infection. The antigens were generated by using a soluble N. meningitidis fHbp...
07:00 , Mar 31, 2016 |  BC Innovations  |  Distillery Techniques

Techniques: Bacteria-derived, sheath-like nanoparticles for antigen delivery in infectious disease vaccines

Drug delivery TECHNOLOGY: Nanoparticles Sheath-like nanoparticles derived from bacteria could be used to deliver vaccine antigens to prevent infections. The sheaths consisted of tubular, heterodimeric structures of ClpV-interacting protein A (VipA) and VipB isolated from the secretion...
07:00 , Aug 4, 2011 |  BC Innovations  |  Distillery Techniques

Technology: Drug platforms

Approach Summary Licensing status Publication and contact information Drug platforms A recombinant Neisseria meningitidis factor H-binding protein (fHBP)-based vaccine for broad protective immunity A recombinant fHBP-based vaccine could provide...
08:00 , Feb 26, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Infectious disease

This week in therapeutics Indication Target/ marker/ pathway Summary Licensing status Publication and contact information Infectious disease...